These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7471719)

  • 1. Alternate complement pathway in porcine sera: lysis of guinea pig erythrocytes.
    Renshaw HW; Gilmore RJ
    Comp Immunol Microbiol Infect Dis; 1980; 3(4):473-84. PubMed ID: 7471719
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the hemolytic activity of the classical and alternative pathway of complement in various animal species.
    Tanaka S; Kitamura F; Suzuki T
    Complement; 1987; 4(1):33-41. PubMed ID: 3568630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of erythrocytes from 4 animal species in the determination of hemolytic activity in classical and alternative pathways of bovine complement].
    Boulard C; Bencharif F
    Comp Immunol Microbiol Infect Dis; 1984; 7(1):27-34. PubMed ID: 6744811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes.
    Van Dijk H; Rademaker PM; Willers JM
    J Immunol Methods; 1980; 36(1):29-39. PubMed ID: 7204994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of zinc on lysis of sheep erythrocytes by guinea pig C4-deficient serum.
    Evans BD; Amiraian K
    Mol Immunol; 1987 Dec; 24(12):1345-50. PubMed ID: 3431554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by xenogeneic red blood cells.
    Edwards J
    Transplantation; 1981 Mar; 31(3):226-7. PubMed ID: 7233531
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of the sensitivity of erythrocytes to lysis by heterologous sera via the alternative complement pathway.
    Van Dijk H; Heezius E; Van Kooten PJ; Rademaker PM; Van Dam R; Willers JM
    Vet Immunol Immunopathol; 1983 May; 4(4):469-77. PubMed ID: 6868341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine alternative pathway activation by unsensitized rabbit red blood cells.
    Leid RW; Coley SC; Blanchard DP; Perryman LE
    Vet Immunol Immunopathol; 1985 May; 9(1):71-85. PubMed ID: 4024451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the haemolytic complement of the dromedary camel (Camelus dromedarius). II. Alternate complement pathway haemolytic activity in serum.
    Olaho-Mukani W; Nyang'ao JN; Kimani JK; Omuse JK
    Vet Immunol Immunopathol; 1995 Sep; 48(1-2):169-76. PubMed ID: 8533311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of complement activity in turkeys: evidence for classical and alternative complement pathways.
    Ellis MG; Lamont SJ; Arp LH
    Poult Sci; 1989 May; 68(5):646-50. PubMed ID: 2666975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on activation and levels of haemolytic complement of buffalo (Bubalus bubalis). II. Alternate complement pathway activity in serum.
    Arya A; Goel MC
    Vet Immunol Immunopathol; 1992 Jan; 30(4):411-8. PubMed ID: 1546445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro inhibition of the classical pathway of human complement by polymyxin B.
    Asghar SS; Boot T; van der Helm HJ
    Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the optimal reaction conditions for assay of the mouse alternative complement pathway.
    Van Dijk H; Rademaker PM; Klerx JP; Willers JM
    J Immunol Methods; 1985 Dec; 85(2):233-43. PubMed ID: 4078314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.
    Zhang Y; Suankratay C; Zhang X; Jones DR; Lint TF; Gewurz H
    Immunology; 1999 Aug; 97(4):686-92. PubMed ID: 10457224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway.
    Chaplin H; Freedman J; Massey A; Monroe MC
    Transfusion; 1980; 20(3):256-62. PubMed ID: 7385321
    [No Abstract]   [Full Text] [Related]  

  • 20. The quantitation of alternative pathway complement function by timed lysis assay.
    Jones BM
    J Immunol Methods; 1979; 29(3):287-92. PubMed ID: 114593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.